Start-Up News January 2008
Noteworty news from medtech start-ups. In this issue: NOTES companies promise the least invasive surgery, with brief profiles of Apollo Endosurgery, Minos Medical and Cardiorobotics. (Adapted from "NOTES Companies Sing an Upbeat Tune," START-UP, December 2007.)
You may also be interested in...
There was an almost dot-com-like euphoria about NOTES at 2007's annual meetings of endoscopists and surgeons. NOTES (natural orifice translumenal endoscopic surgery) is being described as a revolution in minimally invasive surgery, incisionless surgery, or at the very least, a major advance over laparoscopy. It represents a billion-dollar category not yet dominated by the companies that gained preeminence in the $4 billion worldwide laparoscopy market. But most companies in the area agree that the NOTES revolution isn't going to happen overnight. The challenge for today is to create products and technologies for procedures that can happen in high volume in the near term, while waiting for more advanced NOTES procedures to come about.
Robotic surgery systems represent one of the fastest growing segments of the overall endoscopic surgery products market. These technologies allow surgeons to perform complex microsurgical tasks with greater precision and smaller incisions, thereby improving cosmesis, reducing postoperative pain, and shortening the length of hospital stay.
Lilly announced it signed strategic international agreements with four diabetes companies to advance connected solutions and streamline care for people with diabetes in markets outside of the US.